Skip to main content

Table 2 Lipid testing in the past 5 years by sex, age & cardiovascular disease (CVD) risk

From: Relationship between cardiovascular risk and lipid testing in one health care system: a retrospective cohort study

Row(%) Low CVD risk (<10 %) Moderate CVD risk (10-20 %) High CVD risk (>20 %) Cannot determine CVD risk
Lipid tests Lipid tests Lipid tests
a) Men
Age 0 1 2 3+ Total 0 1 2 3+ Total 0 1 2 3+ Total Total
25-34 62.4 26.9 7.4 3.3 1654 50.0 25.0 12.5 12.5 8 0.0 100.0 0.0 0.0 1 643
35-44 43.1 38.1 11.6 7.1 3478 36.9 34.9 16.2 12.1 464 33.3 19.4 16.7 30.6 36 1312
45-54 29.7 42.6 17.5 10.2 2332 27.8 37.1 20.8 14.3 2631 28.3 32.5 19.1 20.2 754 1416
55-64 25.0 40.3 23.5 11.2 196 21.8 37.2 23.3 17.6 2909 21.4 33.7 23.0 21.9 2478 1117
65-79 0.0 0.0 100.0 0.0 1 14.0 29.1 28.4 28.4 278 19.1 28.1 24.4 28.4 2476 356
Total 42.7 37.1 12.8 7.4 7661 25.1 36.7 21.9 16.3 6290 21.4 31.1 23.1 24.5 5745 4844
b) Women
Age 0 1 2 3+ Total 0 1 2 3+ Total 0 1 2 3+ Total Total
25-34 70.1 21.9 4.9 3.3 3259      0      0 438
35-44 47.0 35.2 11.6 6.3 6436 31.2 16.9 16.9 35.1 77 0.0 80.0 0.0 20.0 5 724
45-54 29.2 41.3 19.3 10.3 7993 29.0 34.4 20.1 16.5 780 18.1 22.3 22.3 37.2 94 1079
55-64 22.4 38.7 23.0 15.8 5485 21.2 33.9 26.3 18.6 2180 21.8 26.6 22.6 29.1 399 999
65-79 20.1 35.5 25.6 18.7 1019 21.7 32.4 24.6 21.3 2341 23.1 32.0 19.8 25.2 1300 456
Total 37.5 36.2 16.4 9.9 24192 22.7 33.1 24.5 19.7 5378 22.5 20.4 20.5 26.6 1798 3696
  1. Yellow shading indicates more testing than recommended by the United States Preventive Services Task Force (USPSTF) for persons with low CVD risk. Green shading indicates less testing than recommended for persons at moderate- and high-risk and who are not already on statins. Cross-hatch lines signify risk categories with no study subjects
\